2018
DOI: 10.1016/j.ejphar.2017.12.038
|View full text |Cite|
|
Sign up to set email alerts
|

Secoisolariciresinol diglucoside inhibits adipogenesis through the AMPK pathway

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
8
0

Year Published

2018
2018
2022
2022

Publication Types

Select...
8
1
1

Relationship

0
10

Authors

Journals

citations
Cited by 19 publications
(12 citation statements)
references
References 44 publications
0
8
0
Order By: Relevance
“…Because of estrogen agonist or antagonist properties, flaxseed and its lignan precursor, SDG, affect pregnancy outcome or reproductive development in rats [ 52 ]. Moreover, SDG inhibits adipogenesis by activating AMPK α , suggesting it could be an attractive therapeutic candidate for the treatment of obesity [ 53 ]. We know that fat metabolism and reproduction are associated with aging [ 54 ].…”
Section: Discussionmentioning
confidence: 99%
“…Because of estrogen agonist or antagonist properties, flaxseed and its lignan precursor, SDG, affect pregnancy outcome or reproductive development in rats [ 52 ]. Moreover, SDG inhibits adipogenesis by activating AMPK α , suggesting it could be an attractive therapeutic candidate for the treatment of obesity [ 53 ]. We know that fat metabolism and reproduction are associated with aging [ 54 ].…”
Section: Discussionmentioning
confidence: 99%
“…Equol is a secondary metabolite of the soy isoflavone daidzein that is produced by intestinal bacteria, which is approximately produced by 30% of the population but shows the strongest binding affinity and estrogenic activities, especially for ERβ (estrogen receptor beta). , Plant lignans are present in foods such as whole grains, seeds and nuts, and fruits and vegetables . Secoisolariciresinol, a typical lignan present in the human diet, exists abundantly in flaxseeds . Its metabolites, enterolactone and enterodiol, are produced by microorganisms in the colon and can affect estrogen’s function in the body .…”
Section: Introductionmentioning
confidence: 99%
“…In a clinical study, Zhang et al reported that a daily supplement of 600 mg SDG for 8 weeks in patients with hypercholesterolemia reduces plasma total cholesterol, low-density lipoprotein cholesterol, and fasting blood glucose levels [46]. Kang et al reported that supplementation with SDG (50 mg/kg/d) inhibits fat formation in obese mice induced by a high-fat diet by reducing Ppar protein expression [47]. Pan et al further demonstrated the beneficial effects of SDG in a randomized, double-blind trial of 68 patients with type 2 diabetes who were given 360 mg of SDG daily for 12 weeks.…”
Section: Discussionmentioning
confidence: 99%